0.65
0.02 (3.17%)
0.02 (3.17%)
Upgrade to Real-Time
Market Closed
Low
0.0002
High
0.97
Best deals to access real time data! |
|
Small Cap Pro
Monthly Subscription
for only
|
|
Canna Trader Pro
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| NovAccess Global Inc (PK) | XSNX | OTCMarkets | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.02 | 3.17% | 0.65 | 16:30:42 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.6875 | 0.6499 | 0.69 | 0.65 | 0.63 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 0.57 | 0.85 | 0.28 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 12 | 6,616 | $ 0.653049 | $ 4,321 | - | 0.0002 - 0.97 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:12:45 | 500 | $ 0.65 | USD |
Period:
Draw Mode:
NovAccess Global Inc (PK) Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 8.78M | 13.51M | 1.58M | $ - | $ - | - | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| 8.43k | $ - | - | - | - |
NovAccess Global (PK) News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical XSNX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.70 | 0.74 | 0.48 | 0.6408819 | 7,078 | -0.05 | -7.14% |
| 1 Month | 0.7301 | 0.96 | 0.48 | 0.7389469 | 9,216 | -0.0801 | -10.97% |
| 3 Months | 0.49845 | 0.97 | 0.42 | 0.6755945 | 7,694 | 0.15155 | 30.4% |
| 6 Months | 0.44 | 0.97 | 0.38 | 0.6086967 | 7,570 | 0.21 | 47.73% |
| 1 Year | 0.0002 | 0.97 | 0.0002 | 0.0031324 | 1,343,779 | 0.6498 | 324,900.0% |
| 3 Years | 0.0012 | 0.97 | 0.0002 | 0.0010234 | 2,930,905 | 0.6488 | 54,066.67% |
| 5 Years | 0.0021 | 0.97 | 0.0001 | 0.0012244 | 4,124,276 | 0.6479 | 30,852.38% |
NovAccess Global (PK) Description
| NovAccess Global Inc. is a biopharmaceutical company that is developing novel immunotherapies to treat brain tumor patients in the United States with plans to expand globally. We specialize in cutting-edge research related to utilizing a patient's own immune system to attack the cancer. We have expertise in successfully executing clinical trials, bringing products to market and increasing market size of products through our advisory board. Our scientists are well versed in immunology, stem cell biology, neuroscience, molecular biology, imaging, small molecules development, gene therapy and other technical assays needed for protein and genetic analysis of cancer cells. NovAccess operates as a research and development (R&D) company out of Ohio and California, and our executive management and scientific advisory board provides over 15 years of extensive experience in all aspects of biopharmaceutical R&D and commercialization of drug candidates. We guide our performance by striving to deliver consistently on the following core objectives: (1) Accountability- taking responsibility for providing safe and effective options for patients; (2) Integrity- doing what is ethically right for the patient; (3) Excellence- doing your best and working hard; and (4) Teamwork- bringing together a strong working team to deliver the best products for brain tumor patients. |
